Home » 3D Signatures Files to Offer C$5M in Common Stock

3D Signatures Files to Offer C$5M in Common Stock

Jul 19, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Toronto-based 3D Signatures announced today that it has filed paperwork with Canadian regulators to privately sell up to 12.5 million shares of its common stock in the US for a total of C$5 million ($4 million).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

What's Popular?

In Molecular Diagnostics

  1. Myriad Genetics' Breast Cancer Recurrence Test Wins Positive Coverage From Palmetto, Anthem

  2. ASCO Updates NSCLC Guidelines With New Directives for Genomic Testing

  3. Dutch Researchers Develop ThromboSeq Test to Detect Lung Cancer

  4. Great Basin in Default of Senior Notes for $18.3M

  5. Biocept, UT Southwestern Partner for ALK Liquid Biopsy Study

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.